CENTER FOR NEUROLOGICAL STUDIES (EIN 452463347) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

JOHN RUSSELL

Phone

2482773334

Tax Period

2019-06-01 to 2020-05-31

CENTER FOR NEUROLOGICAL STUDIES, founded in 2011, is a community nonprofit that reported $1.8M in total revenue in fiscal year 2019. Revenue surged 26% from the prior year, signaling strong growth momentum.

Mission

TO ADVANCE THE SCIENTIFIC RESEARCH OF NEUROIMAGING METHODS TO TRANSLATE NEW INSIGHTS INTO IMPROVE DIAGNOSIS OF BRAIN INJURY AND PROVIDE EDUCATIONAL RESOURCES OF THESE FINDINGS. PROVIDE RESOURCES AND SUPPORT TO OTHER ORGANIZATIONS THAT PROVIDE EDUCATION MATERIALS OF BRAIN DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $123,269

Program Service Revenue $1,630,788

Investment Income $523

Other Revenue $0

TOTAL REVENUE $1,754,580

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,086,963

Fundraising Expenses $16,610

Program Expenses $1,176,306

Other Expenses $676,494

TOTAL EXPENSES $1,780,067

Year-over-Year Comparison

	2019	2018	Change
Revenue	$1,754,580	$1,387,092	+0.3%
Expenses	$1,780,067	$1,715,264	+0.0%
Net Income	$-25,487	$-328,172	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$199,300

Total Directors

$199,300

Key Employees

$202,100

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RANDALL R BENSON MD	VICE PRESIDE	40.00	Key Emp	$202,100	$0	$202,100
JOHN RUSSELL	CEO/EXECUTIV	40.00	Officer Director	$199,300	$0	$199,300
MELVIN PATTON MAJOR USA RET	DIRECTOR	3.00	Director	$0	$0	$0
FRANCIS BARAZSU	DIRECTOR	3.00	Director	$0	$0	$0
DAVID DORAN	DIRECTOR	3.00	Director	$0	$0	$0
RANDY DORAN	DIRECTOR	3.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	$1,754,580	$1,780,067	$869,025	$-25,487
2019	$1,387,092	$1,715,264	$650,271	$-328,172
2018	$1,478,095	$1,533,812	$952,864	$-55,717

CENTER FOR NEUROLOGICAL STUDIES